Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

962 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of upfront high-dose chemotherapy plus rituximab followed by autologous peripheral blood stem cell transplantation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a multicenter prospective phase II study (JSCT-NHL04).
Murayama T, Fukuda T, Okumura H, Sunami K, Sawazaki A, Maeda Y, Tsurumi H, Uike N, Hidaka T, Takatsuka Y, Eto T, Tsuda H, Fujisaki T, Miyamoto T, Tsuneyoshi N, Iyama S, Nagafuji K, Harada M. Murayama T, et al. Among authors: okumura h. Int J Hematol. 2016 Jun;103(6):676-85. doi: 10.1007/s12185-016-1976-4. Epub 2016 Mar 21. Int J Hematol. 2016. PMID: 27084252 Clinical Trial.
Prospective observational study on the first 51 cases of peripheral blood stem cell transplantation from unrelated donors in Japan.
Goto T, Tanaka T, Sawa M, Ueda Y, Ago H, Chiba S, Kanamori H, Nishikawa A, Nougawa M, Ohashi K, Okumura H, Tanimoto M, Fukuda T, Kawashima N, Kato T, Okada K, Nagafuji K, Okamoto SI, Atsuta Y, Hino M, Tanaka J, Miyamura K. Goto T, et al. Among authors: okumura h. Int J Hematol. 2018 Feb;107(2):211-221. doi: 10.1007/s12185-017-2341-y. Epub 2017 Oct 13. Int J Hematol. 2018. PMID: 29027623
A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma.
Fuchida SI, Sunami K, Matsumoto M, Okumura H, Murayama T, Miyamoto T, Otsuka E, Fujishima N, Izumi T, Tamaki S, Hiramatsu Y, Kuroda Y, Shimazaki C, Akashi K, Harada M; Japan Study Group for Cell Therapy and Transplantation (JSCT). Fuchida SI, et al. Among authors: okumura h. Int J Hematol. 2019 Jan;109(1):107-114. doi: 10.1007/s12185-018-2543-y. Epub 2018 Oct 4. Int J Hematol. 2019. PMID: 30284685 Clinical Trial.
Impact of a Low CD34+ Cell Dose on Allogeneic Peripheral Blood Stem Cell Transplantation.
Yamamoto C, Ogawa H, Fukuda T, Igarashi A, Okumura H, Uchida N, Hidaka M, Nakamae H, Matsuoka KI, Eto T, Ichinohe T, Atsuta Y, Kanda Y. Yamamoto C, et al. Among authors: okumura h. Biol Blood Marrow Transplant. 2018 Apr;24(4):708-716. doi: 10.1016/j.bbmt.2017.10.043. Epub 2017 Nov 28. Biol Blood Marrow Transplant. 2018. PMID: 29196077 Free article. Clinical Trial.
Correction to: A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma.
Fuchida SI, Sunami K, Matsumoto M, Okumura H, Murayama T, Miyamoto T, Otsuka E, Fujishima N, Izumi T, Tamaki S, Hiramatsu Y, Kuroda Y, Shimazaki C, Akashi K, Harada M; Japan Study Group for Cell Therapy and Transplantation (JSCT). Fuchida SI, et al. Among authors: okumura h. Int J Hematol. 2019 Jan;109(1):131. doi: 10.1007/s12185-018-2557-5. Int J Hematol. 2019. PMID: 30406327
A retrospective analysis of haplo-identical HLA-mismatch hematopoietic transplantation without posttransplantation cyclophosphamide for GVHD prophylaxis in patients with adult T-cell leukemia-lymphoma.
Yoshimitsu M, Utsunomiya A, Fuji S, Fujiwara H, Fukuda T, Ogawa H, Takatsuka Y, Ishitsuka K, Yokota A, Okumura H, Ishii K, Nishikawa A, Eto T, Yonezawa A, Miyashita K, Tsukada J, Tanaka J, Atsuta Y, Kato K; ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation. Yoshimitsu M, et al. Among authors: okumura h. Bone Marrow Transplant. 2019 Aug;54(8):1266-1274. doi: 10.1038/s41409-018-0400-5. Epub 2018 Dec 13. Bone Marrow Transplant. 2019. PMID: 30546068
Prospective evaluation of minimal residual disease monitoring to predict prognosis of adult patients with Ph-negative acute lymphoblastic leukemia.
Nagafuji K, Miyamoto T, Eto T, Ogawa R, Okumura H, Takase K, Kawano N, Miyazaki Y, Fujisaki T, Wake A, Ohno Y, Kurokawa T, Kamimura T, Takamatsu Y, Yokota S, Akashi K. Nagafuji K, et al. Among authors: okumura h. Eur J Haematol. 2019 Sep;103(3):164-171. doi: 10.1111/ejh.13268. Epub 2019 Jul 5. Eur J Haematol. 2019. PMID: 31132205
Low-dose anti-thymocyte globulin for GVHD prophylaxis in HLA-matched allogeneic peripheral blood stem cell transplantation.
Shiratori S, Sugita J, Ota S, Kasahara S, Ishikawa J, Tachibana T, Hayashi Y, Yoshimoto G, Eto T, Iwasaki H, Harada M, Matsuo K, Teshima T; Japan Study Group for Cell Therapy and Transplantation (JSCT). Shiratori S, et al. Bone Marrow Transplant. 2021 Jan;56(1):129-136. doi: 10.1038/s41409-020-0985-3. Epub 2020 Jul 5. Bone Marrow Transplant. 2021. PMID: 32624582 Clinical Trial.
Clinical features and chromosomal/genetic aberration in adult acute lymphoblastic leukemia in Japan: results of Fukuoka Blood & Marrow Transplant Group Studies ALL MRD 2002 and 2008.
Morishige S, Miyamoto T, Eto T, Uchida N, Kamimura T, Miyazaki Y, Ogawa R, Okumura H, Fujisak T, Iwasaki H, Kawano N, Wake A, Ohta T, Takamatsu Y, Kurokawa T, Ito Y, Maeda T, Akashi K, Nagafuji K. Morishige S, et al. Among authors: okumura h. Int J Hematol. 2021 Jun;113(6):815-822. doi: 10.1007/s12185-021-03116-8. Epub 2021 Mar 16. Int J Hematol. 2021. PMID: 33725318 Clinical Trial.
Primary tracheal lymphoma: case report and literature review.
Takami A, Okumura H, Maeda Y, Kumano Y, Asakura H, Oda M, Omura K, Nakao S. Takami A, et al. Among authors: okumura h. Int J Hematol. 2005 Nov;82(4):338-42. doi: 10.1532/IJH97.05087. Int J Hematol. 2005. PMID: 16298827 Review.
962 results